Trials / Completed
CompletedNCT03003104
DMT210 Topical Gel in the Treatment of Acne Rosacea
A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Dermata Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluates the safety, tolerability, and efficacy of DMT210 Gel, 5% when applied twice daily for 12 weeks in adult patients with moderate to severe acne rosacea. Half of participants will receive DMT210 Gel while the other half will receive vehicle control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DMT210 Topical Gel 5% | |
| OTHER | Vehicle Control |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-08-30
- Completion
- 2017-08-30
- First posted
- 2016-12-26
- Last updated
- 2018-04-18
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03003104. Inclusion in this directory is not an endorsement.